Effects of Nicotine and Attention on Frequency Tuning in Auditory Cortex
NCT ID: NCT05018117
Last Updated: 2024-04-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
EARLY_PHASE1
48 participants
INTERVENTIONAL
2022-06-06
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The investigators will use functional magnetic resonance imaging (fMRI) to measure the selectivity of responses in auditory cortex to tones of various frequencies. The investigators will measure the effects of nicotine (administered as chewing gum) and aging on these fMRI response properties. The investigators hypothesize that frequency selectivity will decrease with aging and increase following nicotine administration.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Using Nicotine to Reverse Age-related Auditory Processing Deficits
NCT04971954
Effects of Nicotine on Elements of Attentions in Smokers and Nonsmokers
NCT01034020
Effects of Nicotine on Brain Activity as Measured by fMRI
NCT01037153
The Effect of Nicotine on Arousal, Cognition and Social Cognition in Young and Elderly Healthy Subjects.
NCT01181934
Effect Of Nicotine on Neurocognitive Performance of Cigarette Smokers
NCT00429208
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Young (18-28 years) participants - nicotine gum
6 mg nicotine gum, one time before fMRI measurements
Nicotine gum
The effects of over-the-counter nicotine gum will be compared to a placebo gum
Old (60-85 years) participants - nicotine gum
6 mg nicotine gum, one time before fMRI measurements
Nicotine gum
The effects of over-the-counter nicotine gum will be compared to a placebo gum
Young (18-28 years) participants - placebo gum
placebo gum, one time before fMRI measurements
Placebo gum
The effects of over-the-counter nicotine gum will be compared to a placebo gum
Old (60-85 years) participants - placebo gum
placebo gum, one time before fMRI measurements
Placebo gum
The effects of over-the-counter nicotine gum will be compared to a placebo gum
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Nicotine gum
The effects of over-the-counter nicotine gum will be compared to a placebo gum
Placebo gum
The effects of over-the-counter nicotine gum will be compared to a placebo gum
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* smokers with a score between 3 and 10 on the Fagerström index of smoking dependency
* history of psychiatric illness, neurological disorders, diabetes mellitus, renal failure, or cardiovascular disease
* regular use of prescription medications (excluding oral contraceptives)
* drug dependency
18 Years
85 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute on Aging (NIA)
NIH
University of California, Berkeley
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Michael A Silver, PhD
Role: PRINCIPAL_INVESTIGATOR
University of California, Berkeley
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of California, Berkeley
Berkeley, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2018-12-11682
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.